Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol

BACKGROUND: Burkitt lymphoma (BL) is treated with short, intensive, noncross resistant multidrug chemotherapy regimens. The management of this aggressive lymphoma is a challenge in our resource-limited setting, and the published data from India is scarce. AIM: This retrospective study aims to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Patekar, Mukesh, Gogia, Ajay, Tiwari, Akash, Kumar, Lalit, Sharma, Atul, Mallick, Soumya Ranjan, Sharma, Mehar Chand, Thulkar, Sanjay, Gupta, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma cell disorder
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069339/
https://www.ncbi.nlm.nih.gov/pubmed/30112340
http://dx.doi.org/10.4103/sajc.sajc_230_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069339/
https://www.ncbi.nlm.nih.gov/pubmed/30112340
http://dx.doi.org/10.4103/sajc.sajc_230_17

Ejemplares similares